Graphene stocks
Zentek Ltd. (NASDAQ: ZTEK) announced on September 16, 2026, the execution of a definitive distribution agreement with a major North American medical supply distributor for its ZenGuard™--enhanced surgical masks and HVAC filters.
Key highlights include:
- Commercial Milestone: The agreement includes an initial purchase order valued at $2.5 million, marking a significant step in the commercialization of the company's graphene--based antimicrobial technology.
- Strategic Expansion: This partnership facilitates the company's entry into the high--volume hospital and commercial building filtration markets across the United States and Canada.
- Regulatory Compliance: The rollout follows recent regulatory clearances and successful industrial--scale validation of the coating's efficacy in neutralizing airborne pathogens.
Management characterized the agreement as a "transformative commercial step" that validates the scalability of the ZenGuard™ production process. Deliveries under the new contract are scheduled to commence in November 2026.